Dalfampridine and Physical Therapy for MS Mobility

Recruiting Phase 3 NCT06136728

Study Description

Combining Dalfampridine Medication and Physical Therapy to Improve Walking in Multiple Sclerosis

Study Details

Registry ID:
NCT06136728
Conditions:
Multiple Sclerosis
Phase:
Phase 3
Target Enrollment:
48 participants
Start Date:
Age Range:
25–75 years
Healthy Volunteers:
No

Study Locations (1 site)

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →